Mechanisms of CpG-induced CD40 expression on murine bone marrow-derived dendritic cells

References

• Belz G. T., Nutt S. L.. Transcriptional programming of the dendritic cell network. Nat. Rev. Immunol.. 2012; 12:101–113.
   PubMed Web of Science ®Google Scholar
• Boudreau J. E., Bonehill A., Thielemans K., Wan Y.. Engineering dendritic cells to enhance cancer immunotherapy. Mol Ther.. 2011; 19:841–853.
   PubMed Web of Science ®Google Scholar
• Zhou Y., Zhang Y., Yao Z., Moorman J. P., Jia Z.. Dendritic cell-based immunity and vaccination against hepatitis C virus infection. Immunology. 2012; 136:385–396.
   PubMed Web of Science ®Google Scholar
• O'Sullivan B. J., Pai S., Street S., . Immunotherapy with costimulatory dendritic cells to control autoimmune inflammation. J. Immunol.. 2011; 187:4018–4030.
   PubMed Web of Science ®Google Scholar
• Zanoni I., Granucci F.. The regulatory role of dendritic cells in the induction and maintenance of T-cell tolerance. Autoimmunity. 2011; 44:23–32.
   Web of Science ®Google Scholar
• Mathieu M., Cotta-Grand N., Daudelin J. F., . CD40-activated B cells can efficiently prime antigen-specific naive CD8+T cells to generate effector but not memory T cells. PLoS One. 2012; 7:e30139.
   Google Scholar
• van Duivenvoorde L. M., van Mierlo G. J., Boonman Z. F., Toes R. E.. Dendritic cells: vehicles for tolerance induction and prevention of autoimmune diseases. Immunobiology. 2006; 211:627–632.
   PubMed Web of Science ®Google Scholar
• Ma D. Y., Clark E. A.. The role of CD40 and CD154/CD40L in dendritic cells. Semin. Immunol.. 2009; 21:265–272.
   PubMed Web of Science ®Google Scholar
• Rothoeft T., Balkow S., Krummen M., . Structure and duration of contact between dendritic cells and T cells are controlled by T cell activation state. Eur. J. Immunol.. 2006; 36:3105–3117.
   Google Scholar
• Peters A. L., Stunz L. L., Bishop G. A.. CD40 and autoimmunity: the dark side of a great activator. Semin. Immunol.. 2009; 21:293–300.
   PubMed Web of Science ®Google Scholar
• Ponomarev E. D., Shriver L. P., Dittel B. N.. CD40 expression by microglial cells is required for their completion of a two-step activation process during central nervous system autoimmune inflammation. J. Immunol.. 2006; 176:1402–1410.
   Google Scholar
• Crispin J. C., Vargas-Rojas M. I., Monsivais-Urenda A., Alcocer-Varela J.. Phenotype and function of dendritic cells of patients with systemic lupus erythematosus. Clin. Immunol.. 2012; 143:45–50.
   PubMed Web of Science ®Google Scholar
• Qian Y., Giltiay N., Xiao J., . Deficiency of Act1, a critical modulator of B cell function, leads to development of Sjogren's syndrome. Eur. J. Immunol.. 2008; 38:2219–2228.
   PubMed Web of Science ®Google Scholar
• Ramgolam V. S., Sha Y., Marcus K. L., . B cells as a therapeutic target for IFN-beta in relapsing-remitting multiple sclerosis. J. Immunol.. 2011; 186:4518–4526.
   PubMed Web of Science ®Google Scholar
• Nakken B., Munthe L. A., Konttinen Y. T., . B-cells and their targeting in rheumatoid arthritis–current concepts and future perspectives. Autoimmun. Rev.. 2011; 11:28–34.
   PubMed Web of Science ®Google Scholar
• Toubi E., Shoenfeld Y.. The role of CD40-CD154 interactions in autoimmunity and the benefit of disrupting this pathway. Autoimmunity. 2004; 37:457–464.
   PubMed Web of Science ®Google Scholar
• Robak E., Robak T.. Novel and emerging drugs for systemic lupus erythematosus: mechanism of action and therapeutic activity. Curr. Med. Chem.. 2012; 19:438–453.
   PubMed Web of Science ®Google Scholar
• Li Y., Berke I. C., Modis Y.. DNA binding to proteolytically activated TLR9 is sequence-independent and enhanced by DNA curvature. EMBO J.. 2012; 31:919–931.
   PubMed Web of Science ®Google Scholar
• Miranda-Hernandez S., Gerlach N., Fletcher J. M., . Role for MyD88, TLR2 and TLR9 but not TLR1, TLR4 or TLR6 in experimental autoimmune encephalomyelitis. J. Immunol.. 2011; 187:791–804.
   PubMed Web of Science ®Google Scholar
• Xie H., Hua C., Sun L., . 17beta-estradiol induces CD40 expression in dendritic cells via MAPK signaling pathways in a minichromosome maintenance protein 6-dependent manner. Arthritis Rheum.. 2011; 63:2425–2435.
   Google Scholar
• Hua C., Yang Y., Sun L., . Chaetoglobosin F, a small molecule compound, possesses immunomodulatory properties on bone marrow-derived dendritic cells via TLR9 signaling pathway. Immunobiology. 2012.
   Google Scholar
• Lam Q. L., Zheng B. J., Jin D. Y., Cao X., Lu L.. Leptin induces CD40 expression through the activation of Akt in murine dendritic cells. J. Biol. Chem.. 2007; 282:27587–27597.
   Google Scholar
• Nakasa T., Shibuya H., Nagata Y., Niimoto T., Ochi M.. The inhibitory effect of microRNA-146a expression on bone destruction in collagen-induced arthritis. Arthritis Rheum.. 2011; 63:1582–1590.
   PubMed Web of Science ®Google Scholar
• Su B., Karin M.. Mitogen-activated protein kinase cascades and regulation of gene expression. Curr. Opin. Immunol.. 1996; 8:402–411.
   PubMed Web of Science ®Google Scholar
• Stanczyk J., Pedrioli D. M., Brentano F., . Altered expression of MicroRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis. Arthritis Rheum.. 2008; 58:1001–1009.
   PubMed Web of Science ®Google Scholar
• Nakasa T., Miyaki S., Okubo A., . Expression of microRNA-146 in rheumatoid arthritis synovial tissue. Arthritis Rheum.. 2008; 58:1284–1292.
   PubMed Web of Science ®Google Scholar
• Kawai T., Akira S.. TLR signaling. Cell Death Differ.. 2006; 13:816–825.
   PubMed Web of Science ®Google Scholar
• Suttles J., Stout R. D.. Macrophage CD40 signaling: a pivotal regulator of disease protection and pathogenesis. Semin. Immunol.. 2009; 21:257–264.
   PubMedGoogle Scholar
• Suzuki M., Zheng X., Zhang X., . Inhibition of allergic responses by CD40 gene silencing. Allergy. 2009; 64:387–397.
   Google Scholar
• Suzuki M., Zheng X., Zhang X., . A novel allergen-specific therapy for allergy using CD40-silenced dendritic cells. J Allergy Clin Immunol.. 2010; 125:737–743.
   Google Scholar
• Qin H., Wilson C. A., Lee S. J., Zhao X., Benveniste E. N.. LPS induces CD40 gene expression through the activation of NF-kappaB and STAT-1alpha in macrophages and microglia. Blood. 2005; 106:3114–3122.
   PubMed Web of Science ®Google Scholar
• Nguyen V. T., Benveniste E. N.. Critical role of tumor necrosis factor-alpha and NF-kappa B in interferon-gamma -induced CD40 expression in microglia/macrophages. J. Biol. Chem.. 2002; 277:13796–13803.
   Google Scholar
• Qin H., Wilson C. A., Lee S. J., Benveniste E. N.. IFN-beta-induced SOCS-1 negatively regulates CD40 gene expression in macrophages and microglia. FASEB J.. 2006; 20:985–987.
   PubMedGoogle Scholar
• Benveniste E. N., Nguyen V. T., Wesemann D. R.. Molecular regulation of CD40 gene expression in macrophages and microglia. Brain Behav. Immun.. 2004; 18:7–12.
   PubMedGoogle Scholar
• Shortman K., Liu Y. J.. Mouse and human dendritic cell subtypes. Nat. Rev. Immunol.. 2002; 2:151–161.
   PubMed Web of Science ®Google Scholar
• Colonna M.. TLR pathways and IFN-regulatory factors: to each its own. Eur. J. Immunol.. 2007; 37:306–309.
   PubMed Web of Science ®Google Scholar
• Dowling D., Hamilton C. M., O'Neill S. M.. A comparative analysis of cytokine responses, cell surface marker expression and MAPKs in DCs matured with LPS compared with a panel of TLR ligands. Cytokine. 2008; 41:254–262.
   PubMed Web of Science ®Google Scholar
• Tanos T., Marinissen M. J., Leskow F. C., . Phosphorylation of c-Fos by members of the p38 MAPK family. Role in the AP-1 response to UV light. J. Biol. Chem.. 2005; 280:18842–18852.
   PubMed Web of Science ®Google Scholar
• Aggeli I. K., Gaitanaki C., Beis I.. Involvement of JNKs and p38-MAPK/MSK1 pathways in H2O2-induced upregulation of heme oxygenase-1 mRNA in H9c2 cells. Cell Signal.. 2006; 18:1801–1812.
   PubMed Web of Science ®Google Scholar
• Chen G., Gulbranson D. R., Yu P., Hou Z., Thomson J. A.. Thermal stability of fibroblast growth factor protein is a determinant factor in regulating self-renewal, differentiation, and reprogramming in human pluripotent stem cells. Stem Cells. 2012; 30:623–630.
   PubMed Web of Science ®Google Scholar
• Honda K., Taniguchi T.. IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors. Nat. Rev. Immunol.. 2006; 6:644–658.
   PubMed Web of Science ®Google Scholar
• Krausgruber T., Saliba D., Ryzhakov G., . IRF5 is required for late-phase TNF secretion by human dendritic cells. Blood. 2010; 115:4421–4430.
   PubMedGoogle Scholar
• Tsujimura H., Tamura T., Kong H. J., . Toll-like receptor 9 signaling activates NF-kappaB through IFN regulatory factor-8/IFN consensus sequence binding protein in dendritic cells. J. Immunol.. 2004; 172:6820–6827.
   PubMed Web of Science ®Google Scholar
• Mehta J., Genin A., Brunner M., . Prolonged expression of CD154 on CD4 T cells from pediatric lupus patients correlates with increased CD154 transcription, increased nuclear factor of activated T cell activity, and glomerulonephritis. Arthritis Rheum.. 2010; 62:2499–2509.
   Google Scholar
• Willis R., Seif A. M., McGwin G.Jr., . Effect of hydroxychloroquine treatment on pro-inflammatory cytokines and disease activity in SLE patients: data from LUMINA (LXXV), a multiethnic US cohort. Lupus. 2012; 21:830–835.
   PubMed Web of Science ®Google Scholar
• Gayed M., Gordon C.. Novel treatments for systemic lupus erythematosus. Curr. Opin. Investig. Drugs. 2010; 11:1256–1264.
   PubMedGoogle Scholar
• Tang Y., Luo X., Cui H., . MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins. Arthritis Rheum.. 2009; 60:1065–1075.
   PubMed Web of Science ®Google Scholar
• Gang Wang G., Tam L. S., Li E. K., . Serum and urinary cell-free MiR-146a and MiR-155 in patients with systemic lupus erythematosus. J. Rheumatol.. 2010; 37:2516–2522.
   Google Scholar
• Paik J. H., Jang J. Y., Jeon Y. K., . MicroRNA-146a downregulates NFkappaB activity via targeting TRAF6 and functions as a tumor suppressor having strong prognostic implications in NK/T cell lymphoma. Clin. Cancer Res.. 2011; 17:4761–4771.
   PubMed Web of Science ®Google Scholar
• Hou J., Wang P., Lin L., . MicroRNA-146a feedback inhibits RIG-I-dependent Type I IFN production in macrophages by targeting TRAF6, IRAK1, and IRAK2. J. Immunol.. 2009; 183:2150–2158.
   PubMed Web of Science ®Google Scholar